MétaCan
Menu
Back to cohort
Record W1988927211 · doi:10.1016/j.juro.2010.02.1721

1797 TUMOR SIZE IS ASSOCIATED WITH THE RATE OF SYNCHRONOUS METASTASES IN PATIENTS WITH SMALL RENAL CELL TUMORS

2010· article· en· W1988927211 on OpenAlexaboutno aff
Giovanni Lughezzani, Claudio Jeldres, Lars Budäus, Shahrokh F. Shariat, Maxine Sun, Daniel Liberman, Rodolphe Thuret, Philippe Arjane, Hugues Widmer, Markus Graefen, Paul Perrotte, Francesco Montorsi, Pierre I. Karakiewicz

Bibliographic record

VenueThe Journal of Urology · 2010
Typearticle
Languageen
FieldMedicine
TopicRenal cell carcinoma treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineRenal cell carcinomaArt historyClassicsHistoryInternal medicine

Abstract

fetched live from OpenAlex

You have accessJournal of UrologyKidney Cancer: Advanced II1 Apr 20101797 TUMOR SIZE IS ASSOCIATED WITH THE RATE OF SYNCHRONOUS METASTASES IN PATIENTS WITH SMALL RENAL CELL TUMORS Giovanni Lughezzani, Claudio Jeldres, Lars Budäus, Shahrokh F. Shariat, Maxine Sun, Daniel Liberman, Rodolphe Thuret, Philippe Arjane, Hugues Widmer, Markus Graefen, Paul Perrotte, Francesco Montorsi, and Pierre I. Karakiewicz Giovanni LughezzaniGiovanni Lughezzani Milano, Italy More articles by this author , Claudio JeldresClaudio Jeldres Montreal, Canada More articles by this author , Lars BudäusLars Budäus Hamburg, Germany More articles by this author , Shahrokh F. ShariatShahrokh F. Shariat Montreal, Canada More articles by this author , Maxine SunMaxine Sun Montreal, Canada More articles by this author , Daniel LibermanDaniel Liberman Montreal, Canada More articles by this author , Rodolphe ThuretRodolphe Thuret Montpellier, France More articles by this author , Philippe ArjanePhilippe Arjane Montreal, Canada More articles by this author , Hugues WidmerHugues Widmer Montreal, Canada More articles by this author , Markus GraefenMarkus Graefen Hamburg, Germany More articles by this author , Paul PerrottePaul Perrotte Montreal, Canada More articles by this author , Francesco MontorsiFrancesco Montorsi Milano, Italy More articles by this author , and Pierre I. KarakiewiczPierre I. Karakiewicz Montreal, Canada More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1721AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Small renal masses between 1.1 and 4.0 cm can be visualized and confirmed histologically with a high degree of certainty. We examined the rate of synchronous metastases (SM) in patients with renal cell carcinoma (RCC) 1.1 to 4.0 cm in size within a large population-based tumor registry. METHODS We tested the relationship between tumor size and SM in a population of 27780 patients with small renal masses diagnosed and/or treated with nephrectomy for histologically-proven RCC within 17 SEER registries between 1988 and 2006. Cubic spline analyses and logistic regression models were used to test this relationship after adjusting for other covariables, such as age, gender, race, RCC histological subtype and year of diagnosis. RESULTS Within the study population the rate of SM was 4.5%. Stratification according to 1 cm tumor size intervals revealed that the SM rate increased with increasing tumor size: 1.1-2.0 cm: 3.1%; 2.1-3.0 cm: 4.0%; 3.1-4.0 cm: 5.7% (chi-square trend; p<0.001). Cubic spline analysis showed that rate of SM is starts to increase exponentially when tumor size exceeds 2.5 centimeters. Continuously coded tumor size represented an independent predictor of SM in multivariate regression models (OR: 1.04; p<0.001). When tumor size was divided into 1 cm intervals, patients with 2.1-3.0 and with 3.1-4.0 cm RCCs had respectively a 1.2- and a 1.7-fold higher risk of harboring SM (p<0.05). Finally, advanced age (p<0.001), male gender (p<0.001), African-American race (p=0.03) and more contemporary year of diagnosis (p=0.02) also represented independent predictors of SM. CONCLUSIONS Tumor size is related to SM rate even in patients with small (1.1 to 4.0) RCCs. The rate of SM increases exponentially when tumor size exceeds 2.5 cm. Conversely, no differences in metastatic rates were observed below this threshold. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e697 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Giovanni Lughezzani Milano, Italy More articles by this author Claudio Jeldres Montreal, Canada More articles by this author Lars Budäus Hamburg, Germany More articles by this author Shahrokh F. Shariat Montreal, Canada More articles by this author Maxine Sun Montreal, Canada More articles by this author Daniel Liberman Montreal, Canada More articles by this author Rodolphe Thuret Montpellier, France More articles by this author Philippe Arjane Montreal, Canada More articles by this author Hugues Widmer Montreal, Canada More articles by this author Markus Graefen Hamburg, Germany More articles by this author Paul Perrotte Montreal, Canada More articles by this author Francesco Montorsi Milano, Italy More articles by this author Pierre I. Karakiewicz Montreal, Canada More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.203
Teacher spread0.194 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of UrologySame topicRenal cell carcinoma treatmentFrench-language works237,207